tiprankstipranks
China Jo-Jo Drugstores Releases 2024 Interim Financials Highlighting Revenue Decline
Company Announcements

China Jo-Jo Drugstores Releases 2024 Interim Financials Highlighting Revenue Decline

Story Highlights
  • China Jo-Jo Drugstores operates in the pharmaceutical retail industry in China.
  • The company reported a decrease in revenues and assets for the six months ended September 2024.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Invest with Confidence:

China Jo-Jo Drugstores ( (CJJD) ) has issued an announcement.

China Jo-Jo Drugstores, Inc. released interim financial statements for the six months ended September 30, 2024, revealing a decrease in net revenues from $78.57 million in 2023 to $71.16 million in 2024. The company’s total assets slightly decreased from $95.06 million to $94.19 million, while total liabilities also reduced from $80.76 million to $74.07 million over the same period, impacting its financial positioning.

More about China Jo-Jo Drugstores

China Jo-Jo Drugstores, Inc. is a company based in Hangzhou City, Zhejiang Province, China, primarily operating in the pharmaceutical retail industry. It focuses on providing pharmaceutical products and services through its retail drugstores and online platforms.

YTD Price Performance: 6.01%

Average Trading Volume: 11,608

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $12.91M

Find detailed analytics on CJJD stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles